© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
July 23, 2019
CD20-directed antibody indicated for several cancers and other conditions.
May 10, 2019
Biosimilar guidance provides “clarity” for drug developers.
March 12, 2019
Indicated for breast cancer, and gastric or gastroesophageal junction adenocarcinoma.
March 08, 2019
Only new biosimilars and interchangeables will recieve four-letter suffixes.
February 19, 2019
The report by Magellan Rx Management indicates PMPM, site of service, and Medicaid prices continue to increase.
December 13, 2018
Specialty pharmaceuticals make up a significant part of the current drug market, and their impact is only going to grow over the next few years.
September 03, 2018
Stalled competition hurts consumers and may keep prices higher.
August 24, 2018
Drug Topics recently spoke with the FDA about the role pharmacists can play in patient education.
August 23, 2018
The annual report on generic access and savings shows some impressive numbers for 2017.
August 16, 2018
An unclear naming system for biosimilars could affect patient safety.